Healthcare ❯ Pharmaceuticals ❯ Weight Loss Drugs ❯ Semaglutide

Clinical Trials

FDA Clears Lilly’s Foundayo Pill, Escalating GLP-1 Weight-Loss Rivalry

The approval accelerates a shift toward oral GLP-1 treatments that promise wider, steadier access.

Lancet Analysis: Semaglutide Cuts Major Heart Events Regardless of Weight Loss